[HTML][HTML] Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial
C Hidalgo-Tenorio, S Sequera, MJ Vivancos… - International journal of …, 2024 - Elsevier
Objective Multiple strategies have been utilised to reduce the incidence of HIV, including
PrEP and rapid antiretroviral therapy initiation. The study objectives were to evaluate the …
PrEP and rapid antiretroviral therapy initiation. The study objectives were to evaluate the …
[HTML][HTML] Comparable clinical outcomes with same-day versus rapid initiation of antiretroviral therapy in Taiwan
YC Huang, CJ Yang, HY Sun, CH Lee, PL Lu… - International Journal of …, 2024 - Elsevier
Objectives WHO has recommended same-day antiretroviral therapy (SDART) initiation since
2017; however, higher attrition rates were noted in developing countries. Methods We …
2017; however, higher attrition rates were noted in developing countries. Methods We …
Bictegravir/emtricitabine/tenofovir alafenamide in a multicentre cohort: real-life experience from Spain
M Torralba, G Rodríguez… - Annals of …, 2024 - journals.sagepub.com
Background: The evaluation of bictegravir, emtricitabine, and tenofovir alafenamide
(BIC/FTC/TAF) in clinical trials has shown high rates of virological suppression but …
(BIC/FTC/TAF) in clinical trials has shown high rates of virological suppression but …
[HTML][HTML] Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)
Background A rapid ART initiation approach can be beneficial in people with advanced HIV
disease, in consideration of their high morbidity and mortality. The aim of our study was to …
disease, in consideration of their high morbidity and mortality. The aim of our study was to …
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study
A Ugarte, L De La Mora, E De Lazzari… - Journal of …, 2024 - academic.oup.com
Introduction Rapid initiation of ART after HIV diagnosis is recommended for individual and
public health benefits. However, certain clinical and ART-related considerations hinder …
public health benefits. However, certain clinical and ART-related considerations hinder …
[PDF][PDF] Bictegravir/Emtricitabine/Tenofovir Alafenomide for the Treatment of HIV/Hepatitis B Virus Co-infection in Patients with Cancer and Transplant Recipients
JK Dickter, JA Ross - touchREVIEWS in Infectious …, 2023 - touchinfectiousdiseases.com
For people with HIV/hepatitis B virus (HBV) co-infection who develop comorbidities that
require polypharmacy, treatment may be complicated due to drug interactions and …
require polypharmacy, treatment may be complicated due to drug interactions and …
Comparable Clinical Outcomes with Same-Day Versus Rapid Initiation of Antiretroviral Therapy: A Real-World Retrospective Cohort Study in a Developed Country
YC Huang, CJ Yang, HY Sun, CH Lee, PL Lu, HJ Tang… - 2021 - papers.ssrn.com
Background: Same-day antiretroviral therapy (SDART) initiation is recommended for newly
diagnosed people with HIV (PWH) by the WHO; however, higher attrition rates were noted …
diagnosed people with HIV (PWH) by the WHO; however, higher attrition rates were noted …